Effectiveness of Lymphatic Microsurgical Procedures in the Treatment of Primary Lymphedema
Ming-Huei Cheng, MD, MBA, FACS; Ketan M. Patel, MD IntroductIon: Vascularized lymph node transfer (VLNT) and lymphovenous bypass (LVB) procedures represent physiologic treatment options for symptomatic lymphedema. Secondary causes related to oncologic surgery and/ or radiation have been successfully treated using these surgical procedures. Primary lymphedema represents a poorly understood lymphedematous condition with equally poor understanding of the benefits of microsurgical intervention. The purpose of this study was to review our experience with this patient population to better understand the effectiveness of microsurgical procedures.
MethodS:
A retrospective review of a prospectively maintained database of patients who received microsurgical treatment for primary lymphedema was reviewed. Both LVB and VLNT procedures were used in this patient cohort. Outcomes related to demographics, circumference differences, and symptoms, and quality of life (QoL) changes were evaluated. A validated questionnaire, the LYMQOL, was used to assess QoL outcomes.
reSultS: Thirteen patients were identified and met inclusion criteria. All patients had primary lower extremity lymphedema. Average age and symptom duration was 37.8 years and 162 months, respectively. The average lymphedema stage was classified as Stage II in 66.7% of patients. Average followup was 12.2 months. VLNT was used in most cases (69.2%) while LVB was used in the remainder of patients. The average overall circumference reduction was 3.6 cm with more improvement seen in patients who received VLNT as compared to LVB (4.2cm v. 1.9cm) . Improvements in body weight and cellulitis occurrence was significantly improved in the VLNT cohort (p<0.05). In addition, patient reported QoL domains related to function, appearance, symptoms, and mood were significantly improved following VLNT (p<0.05 in all domains) as compared to LVB (p>0.05 in all domains).
concluSIon: Lymphatic microsurgical procedures are valuable treatment options for patients with primary lymphedema. Vascularized lymph node transfer appears to result in improved overall outcomes as compared to lymphovenous bypass procedures in this specific patient population. Improvements in objective clinical measures (limb circumference, body weight, and cellulitis occurrence) correlate well with improved patient reported quality of life parameters. 1 This may be due to the unnatural appearance of the reconstructed NAC. We present a series of techniques utilized to achieve optimal nipple-areolar reconstruction aesthetics.
Nipple-Areolar Complex

MethodS:
A retrospective review of a single surgeon's practice was performed from January 2008 until December 2014. Patient follow-up ranged from 1 to 8 years. Premastectomy color evaluations of the native nipple-areolar complex were performed. All patients that underwent reconstruction had simultaneous nippleareolar tattooing utilizing a blending method. The specific NAC local flap was determined based on the patient's individual scar pattern.
reSultS: There were a total of 342 patients included; 140 reconstructions were unilateral (41%) and 202 reconstructions were bilateral (59%). Sixty-eight patients (20%) had fading of their tattoo, of which 34 patients (10%) underwent nipple color retouching. The most common area that required additional tattooing was the mastectomy scar. Thirty patients (9%) underwent secondary nipple reconstruction due to loss of nipple projection. One hundred and two patients (30%) developed superficial epidermolysis of the reconstructed NAC which was managed with local wound care alone. There were no cases of full thickness necrosis of the NAC
